Zobrazeno 1 - 10
of 27
pro vyhledávání: '"C.N. Manjunath"'
Autor:
Balbir Singh, Hygriv B. Rao, Ulhas Pandurangi, C.N. Manjunath, Gautam Sharma, Ajay Naik, Ajit Thachil, Sharad Chandra, Vinayakrishnan Rajan, Bart Gerritse, Upendra Kaul, Nakul Sinha, C. Narasimhan, R.K. Premchand Jain, Anil Saxena
Publikováno v:
Indian Heart Journal. 74:194-200
Sudden cardiac death (SCD) continues to be a devastating complication amongst survivors of myocardial infarction (MI). Mortality is high in the initial months after MI. The aims of the INSPIRE-ELR study were to assess the proportion of patients with
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 9:S58-S62
Background: A significant number of patients with prosthetic valve thrombosis have a prothrombin time international normalised ratio in the therapeutic range at presentation. Surgery may not be possible in many patients and traditionally a high inter
Autor:
Anindya Sundar Trivedi, Laxmi H Shetty, Shanmugam Krishnan, Rahul Patil, C.N. Manjunath, T.R. Raghu
Publikováno v:
Indian Heart Journal, Vol 72, Iss 5, Pp 394-397 (2020)
Indian Heart Journal
Indian Heart Journal
Aims To study the risk factors, clinical and angiographic profile of Indian rural youth (under 35yrs) presenting with Premature Coronary Artery Disease (PCAD). Subjects and Methods: The PCAD registry had 1628 patients who were aged below 35 years, of
Autor:
T.R. Raghu, V.K. Chopra, BC Srinivas, P.B. Jayagopal, Veena Nanjappa, Jabir Abdullakutty, C.N. Manjunath, L. Sridhar, P.R. Vaidyanathan, G. Somasekhar, Johny Joseph
Publikováno v:
Indian Heart Journal, Vol 73, Iss 4, Pp 464-469 (2021)
Indian Heart Journal
Indian Heart Journal
Aim: This retrospective study compares admissions and outcomes due to acute decompensated heart failure (ADHF) during the COVID-19 pandemic from 25 March to 25 July 2020 with the historical patient control who were admitted during the same period in
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 71, Iss 6, Pp 464-467 (2019)
Indian Heart Journal, Vol 71, Iss 6, Pp 464-467 (2019)
Objective: Reteplase (recombinant plasminogen activator) is a mutant of alteplase. It has a longer half-life than its parent molecule and has shown better vessel patency rates in acute myocardial infarction. In this study, we analyzed the efficacy an
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 23:876-882
Background and Aim: Chronic rheumatic heart disease (RHD) patients who undergo valve replacement with mechanical valves require lifelong anticoagulation. Acenocoumarol, a vitamin K antagonist has a narrow therapeutic range and wide inter-individual v
Publikováno v:
World Journal for Pediatric and Congenital Heart Surgery. 5:627-630
Congenital absence of the pulmonary valve is a rare congenital cardiac malformation, usually seen in association with tetralogy of Fallot. Patients generally present early in life with respiratory distress or recurrent respiratory tract infections, f
Publikováno v:
Phlebology: The Journal of Venous Disease. 30:441-448
Background Catheter-directed thrombolysis with assisted mechanical thrombolysis is the standard of medical care for proximal deep vein thrombosis. We studied the immediate and intermediate (six months) safety and effectiveness of catheter-directed th
Publikováno v:
Indian Heart Journal, Vol 66, Iss 3, Pp 320-326 (2014)
Background: Diseases of the heart valves constitute a major cause of cardiovascular morbidity and mortality worldwide with rheumatic heart disease (RHD) being the dominant form of valvular heart disease (VHD) in developing nations. The current study
Autor:
Sandhya Ravi, R. Keshava, Thomas Alexander, Rajiv Gupta, J.P.S. Sawhney, C.B. Patil, C.N. Manjunath, Saral Thangam, Annie Sheela, S S Iyengar
Publikováno v:
Indian Heart Journal, Vol 69, Iss 2, Pp 211-216 (2017)
Background: Coronary artery disease (CAD) occurs at younger age in India but only a limited number of studies have evaluated risk factors and management status. This is a multisite observational registry to assess risk factors and treatment patterns